Active Ingredient(s): Atrasentan
Category: Cancer

Xinlay Overview

Atrasentan is an experimental drug that is being studied for the treatment of various types of cancer,[1] including non-small cell lung cancer.[2] It is also being investigated as a therapy for diabetic kidney disease. Atrasentan failed a phase 3 trial for prostate cancer in patients unresponsive to hormone therapy.[3] A second trial confirmed this finding.[4] It is an endothelin receptor antagonist selective for subtype A (ETA)....

Read more Xinlay Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Xinlay Forums:

Be the first to start a discussion about this drug.

Other drugs which contain Atrasentan or a similar ingredient: (1 result)